Roche extends offer for reluctant Illumina; Covidien buys Newport Medical for $108M;

@FierceMedDev: Kodak legacy lives on in spinoffs, startups. Article | Follow @FierceMedDev

> Roche  ($RHHBY) has extended its tender offer for Illumina ($ILMN) until April 20. But Illumina isn't giving in easily: "Illumina's Board of Directors continues to believe that Roche's offer is grossly inadequate, and that Illumina is positioned to create far more value than Roche has offered. Our stockholders clearly agree." Report

> Covidien ($COV) will buy Costa Mesa, CA-based ventilator maker Newport Medical Instruments for about $108 million. Covidien release

> Albany, NY-based AngioDynamics ($ANGO) has entered a strategic relationship with privately held Microsulis Medical. Under the terms of the deal, AngioDynamics has gained the exclusive option to purchase--at any time until Sept. 22, 2013--substantially all of the global assets of the U.K. company, including the microwave ablation technology and its worldwide distribution rights. AngioDynamics/Microsulis release

> Older patients getting a replacement heart valve via a less invasive technique offered by Edwards LifeSciences had similar death rates and risk of stroke at two years compared with those who got a new valve during open-heart surgery, according to a study. News

> Benvenue Medical has launched the Blazer vertebral augmentation system for vertebral compression fractures in the U.S. Benvenue release

And Finally... Metastatic breast cancer patients may finally have another weapon in the fight against their disease: percutaneous cryoablation. Release

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.